TNF-alpha Inhibitors
Over the last decade, the advent of biologic agents has greatly revolutionized therapeutic medicine in the management of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn’s disease, and psoriasis. Elucidation of the complex web of cytokine network and the roles of these cytokines in...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Basel :
Birkhäuser Basel,
2006.
|
Σειρά: | Milestones in Drug Therapy
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- to TNF/pathophysiology of TNF
- History of development of TNF inhibitors
- Pharmacology of TNF inhibitors
- Etanercept in rheumatology
- Etanercept in dermatology and off-label use
- Infliximab in rheumatology
- Infliximab in dermatology, gastroenterology, and off-label use
- Adalimumab in rheumatology
- Adalimumab in dermatology
- A review of the safety of the tumor necrosis inhibitors infliximab, etanercept, and adalimumab.